Abstract
Objectives
Phthalate is one of the endocrine-disrupting chemicals found in many daily consumer products. Chronic exposure to phthalate may associate with obesity and metabolic abnormalities. However, there is limited information showing a direct relationship between phthalate and body compositions. The aim of the study was to determine the association between urinary phthalate concentration and body composition measure among Thai children.
Methods
A cross-sectional analytic study on urinary phthalate concentrations and body composition in elementary school children, aged 6–13 years in Bangkok, was conducted during October 2019 to 2020. Urinary phthalate metabolites; (mono-methyl phthalate-MMP, mono-ethyl phthalate- MEP, mono-buthyl phthalate-MBP, and mono-ethylhexyl phthalate-MEHP), in early morning spot urine samples were measured by liquid chromatography tandem mass spectrometry (LC-MSMS) with a quantitation limit of 1 ng/mL. Phthalate exposures were identified through questionnaires. Body composition was measured by Tanita BC-418®. Multivariate logistic regression analysis was performed to determine significant associations.
Results
A total of 364 children were enrolled in the study (boy 51.4%). After adjusting for confounders (sex, caregiver educations, family income, BMI-SDS: Body mass index-standard deviation score, TV watching, and exercise frequency), total urinary phthalate concentrations were associated with fat mass 8.24 (0.94, 15.53), trunk percent fat 7.69 (3.26, 12.12), arm percent fat 3.69 (0.47, 6.91), arm fat mass 72.88 (1.08, 144.67), and leg fat mass 17.79 (2.37, 33.22).
Conclusions
Higher urinary phthalate concentrations were significantly associated with elevated total fat mass among Thai school-aged children. These findings were not mediated through the degree of obesity defined by BMI. These finding emphasized to be careful when being use phthalate-containing products.
Funding source: the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Award Identifier / Grant number: RA63/090
Acknowledgments
We would like to thank the pediatric residents and pediatric endocrine fellows for their assistance with data and urine collection.
-
Research funding: This study was supported by the Ratchadapiseksompotch Fund (RA63/090), Faculty of Medicine, Chulalongkorn University.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. SV and NE designed the study. NE reviewed literature and wrote first draft of manuscript. KS and SN analyzed urinary Phthalates concentrations. NE and AS collected the clinical data and analyzed data. SV edited and approved the final version of manuscript.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: This study was approved by the Institutional Review Boards of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB No.544/63).
References
1. Bui, TT, Giovanoulis, G, Cousins, AP, Magner, J, Cousins, IT, de Wit, CA. Human exposure, hazard and risk of alternative plasticizers to phthalate esters. Sci Total Environ 2016;541:451–67. https://doi.org/10.1016/j.scitotenv.2015.09.036.Search in Google Scholar PubMed
2. Berger, KP, Kogut, KR, Bradman, A, She, J, Gavin, Q, Zahedi, R, et al.. Personal care product use as a predictor of urinary concentrations of certain phthalates, parabens, and phenols in the HERMOSA study. J Expo Sci Environ Epidemiol 2019;29:21–32. https://doi.org/10.1038/s41370-017-0003-z.Search in Google Scholar PubMed PubMed Central
3. Fisher, M, Arbuckle, TE, MacPherson, S, Braun, JM, Feeley, M, Gaudreau, E. Phthalate and BPA exposure in women and newborns through personal care product use and food packaging. Environ Sci Technol 2019;53:10813–26. https://doi.org/10.1021/acs.est.9b02372.Search in Google Scholar PubMed
4. Koch, HM, Becker, K, Wittassek, M, Seiwert, M, Angerer, J, Kolossa-Gehring, M. Di-n-butylphthalate and butylbenzylphthalate – urinary metabolite levels and estimated daily intakes: pilot study for the German environmental survey on children. J Expo Sci Environ Epidemiol 2007;17:378–87. https://doi.org/10.1038/sj.jes.7500526.Search in Google Scholar PubMed
5. Katsikantami, I, Sifakis, S, Tzatzarakis, MN, Vakonaki, E, Kalantzi, OI, Tsatsakis, AM, et al.. A global assessment of phthalates burden and related links to health effects. Environ Int 2016;97:212–36. https://doi.org/10.1016/j.envint.2016.09.013.Search in Google Scholar PubMed
6. Silva, MJ, Samandar, E, Preau, JLJr, Reidy, JA, Needham, LL, Calafat, AM. Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 2007;860:106–12. https://doi.org/10.1016/j.jchromb.2007.10.023.Search in Google Scholar PubMed
7. Silva, CCV, Jaddoe, VWV, Sol, CM, El Marroun, H, Martinez-Moral, MP, Kannan, K, et al.. Phthalate and bisphenol urinary concentrations, body fat measures, and cardiovascular risk factors in dutch school-age children. Obesity 2021;29:409–17. https://doi.org/10.1002/oby.23082.Search in Google Scholar PubMed PubMed Central
8. Lien, GW, Chen, JH, Tien, FW, Chen, PC, Chen, HW, Hwa, HL, et al.. Dilute-and-shoot enhances sensitivity of phthalate urinary concentrations for assessing the exposure in children. J Hazard Mater 2018;351:124–30. https://doi.org/10.1016/j.jhazmat.2018.02.050.Search in Google Scholar PubMed
9. Wada, K, Sakamoto, H, Nishikawa, K, Sakuma, S, Nakajima, A, Fujimoto, Y, et al.. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci 2007;105:133–7. https://doi.org/10.1254/jphs.fm0070034.Search in Google Scholar PubMed
10. Corbasson, I, Hankinson, SE, Stanek, EJ3rd, Reeves, KW. Urinary bisphenol-A, phthalate metabolites and body composition in US adults, NHANES 1999-2006. Int J Environ Health Res 2016;26:606–17. https://doi.org/10.1080/09603123.2016.1233524.Search in Google Scholar PubMed
11. Hu, G, Bouchard, C, Bray, GA, Greenway, FL, Johnson, WD, Newton, RLJr, et al.. Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults. Diabetes Care 2011;34:1415–8. https://doi.org/10.2337/dc10-2019.Search in Google Scholar PubMed PubMed Central
12. Staiano, AE, Gupta, AK, Katzmarzyk, PT. Cardiometabolic risk factors and fat distribution in children and adolescents. J Pediatr 2014;164:560–5. https://doi.org/10.1016/j.jpeds.2013.10.064.Search in Google Scholar PubMed PubMed Central
13. Weber, DR, Leonard, MBMDMSCE, Zemel, BSPhD. Body composition analysis in the pediatric population. Pediatr Endocrinol Rev 2012;10:130–9.Search in Google Scholar
14. Maynard, LMPWWMA, Roche, AFMDPhD, Chumlea, WCPSSGPhD, Siervogel, RMPhD. Childhood body composition in relation to body mass index. Pediatrics 2001;107:344–50. https://doi.org/10.1542/peds.107.2.344.Search in Google Scholar PubMed
15. Park, HW, Yoo, HY, Kim, CH, Kim, H, Kwak, BO, Kim, KS, et al.. Reference values of body composition indices: the Korean national health and nutrition examination surveys. Yonsei Med J 2015;56:95–102. https://doi.org/10.3349/ymj.2015.56.1.95.Search in Google Scholar PubMed PubMed Central
16. Kai-Yu Xiong, HH, He, H, Zhang, YM, Ni, GX. Analyses of body composition charts among younger and older Chinese children and adolescents aged 5 to 18 years. BMC Publ Health 2012;12:835. https://doi.org/10.1186/1471-2458-12-835.Search in Google Scholar PubMed PubMed Central
17. Chung, S. Body composition analysis and references in children: clinical usefulness and limitations. Eur J Clin Nutr 2019;73:236–42. https://doi.org/10.1038/s41430-018-0322-8.Search in Google Scholar PubMed
18. Wang, L, Hui, SS, Wong, SH. Validity of bioelectrical impedance measurement in predicting fat-free mass of Chinese children and adolescents. Med Sci Monit 2014;20:2298–310. https://doi.org/10.12659/msm.890696.Search in Google Scholar
19. Shashi Chiplonkar, NK, Kajale, N, Veena, E, Ekbote, V, Rubina, MLP, Mandlik, R, et al.. Validation of bioelectric impedance analysis against dual-energy X-ray absorptiometry for assessment of body composition in Indian children aged 5 to 18 years. Indian Pediatr 2017;54:919–24. https://doi.org/10.1007/s13312-017-1182-3.Search in Google Scholar PubMed
20. Ogden, CLCDF, Martin, CB, Freedman, DS, Carroll, MD, Gu, Q, Hales, CM. Trends in obesity prevalence by race and hispanic origin—1999–2000 to 2017-2018. JAMA 2020;324:1208–10. https://doi.org/10.1001/jama.2020.14590.Search in Google Scholar PubMed PubMed Central
21. Ministry of Public Health. Percent of overweight and obesity of school children aged 6-14 year-old; 2022. Available from: https://dashboard.anamai.moph.go.th/dashboard/overweightstudent/index?year=2021.Search in Google Scholar
22. Andrea, L, Deierlein, A, Pajak, A, MaryWolff, SA, Ashley, PA, Windham, G C, et al.. Longitudinal associations of phthalate exposures during childhood and body size measurements in young girls. Epidemiology 2016;27:492–9. https://doi.org/10.1097/ede.0000000000000489.Search in Google Scholar PubMed PubMed Central
23. Wang, H, Zhou, Y, Tang, C, He, Y, Wu, J, Chen, Y, et al.. Urinary phthalate metabolites are associated with body mass index and waist circumference in Chinese school children. PLoS One 2013;8:e56800. https://doi.org/10.1371/journal.pone.0056800.Search in Google Scholar PubMed PubMed Central
24. Lee, I, Palmke, C, Ringbeck, B, Ihn, Y, Gotthardt, A, Lee, G, et al.. Urinary concentrations of major phthalate and alternative plasticizer metabolites in children of Thailand, Indonesia, and Saudi Arabia, and associated risks. Environ Sci Technol 2021;55:16526–37. https://doi.org/10.1021/acs.est.1c04716.Search in Google Scholar PubMed
25. Xia, B, Zhu, Q, Zhao, Y, Ge, W, Zhao, Y, Song, Q, et al.. Phthalate exposure and childhood overweight and obesity: urinary metabolomic evidence. Environ Int 2018;121:159–68. https://doi.org/10.1016/j.envint.2018.09.001.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Original Articles
- The effects of topical iodine containing antiseptics on thyroidal status and early neurodevelopment of preterm infants
- Effect of COVID-19 pandemic on presentation and referral patterns of newly diagnosed children with type 1 diabetes in a developing country
- Influence of the SARS-CoV-2 pandemic on paediatric patients with type 1 diabetes mellitus after one year of follow-up
- Combined diagnostic value of insulin-like growth factor-1, insulin-like growth factor binding protein-3, and baseline luteinizing hormone levels for central precocious puberty in girls
- Differences in the proportion of Croatian adolescents with abnormal individual metabolic syndrome components adjusted to gender and different criterion for individual metabolic syndrome component
- Low HDL-C is a non-fasting marker of insulin resistance in children
- Impact of COVID-19 lockdown on idiopathic central precocious puberty – experience from an Indian centre
- The relationship between metabolic syndrome and bone mineral density in adolescents: analysis of the National Health and Nutrition Examination Survey
- Long-term follow-up of alkaptonuria patients: single center experience
- Local aromatase excess with recruitment of unusual promoters of CYP19A1 gene in prepubertal patients with gynecomastia
- Urinary phthalate concentrations are associated with total fat mass in Thai children
- Clinical profile and aetiologies of delayed puberty: a 15 years’ experience from a tertiary centre in Sudan
- Case Reports
- Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution
- Prepubertal and pubertal gonadal morphology, expression of cell lineage markers and hormonal evaluation in two 46,XY siblings with 17β-hydroxysteroid dehydrogenase 3 deficiency
- Pleomorphism of the HPG axis with NR0B1 gene mutation — a case report of longitudinal follow-up of a proband with central precocious puberty
- Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4
Articles in the same Issue
- Frontmatter
- Original Articles
- The effects of topical iodine containing antiseptics on thyroidal status and early neurodevelopment of preterm infants
- Effect of COVID-19 pandemic on presentation and referral patterns of newly diagnosed children with type 1 diabetes in a developing country
- Influence of the SARS-CoV-2 pandemic on paediatric patients with type 1 diabetes mellitus after one year of follow-up
- Combined diagnostic value of insulin-like growth factor-1, insulin-like growth factor binding protein-3, and baseline luteinizing hormone levels for central precocious puberty in girls
- Differences in the proportion of Croatian adolescents with abnormal individual metabolic syndrome components adjusted to gender and different criterion for individual metabolic syndrome component
- Low HDL-C is a non-fasting marker of insulin resistance in children
- Impact of COVID-19 lockdown on idiopathic central precocious puberty – experience from an Indian centre
- The relationship between metabolic syndrome and bone mineral density in adolescents: analysis of the National Health and Nutrition Examination Survey
- Long-term follow-up of alkaptonuria patients: single center experience
- Local aromatase excess with recruitment of unusual promoters of CYP19A1 gene in prepubertal patients with gynecomastia
- Urinary phthalate concentrations are associated with total fat mass in Thai children
- Clinical profile and aetiologies of delayed puberty: a 15 years’ experience from a tertiary centre in Sudan
- Case Reports
- Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution
- Prepubertal and pubertal gonadal morphology, expression of cell lineage markers and hormonal evaluation in two 46,XY siblings with 17β-hydroxysteroid dehydrogenase 3 deficiency
- Pleomorphism of the HPG axis with NR0B1 gene mutation — a case report of longitudinal follow-up of a proband with central precocious puberty
- Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4